Importance of Deal Activity in Pharmaceutical Industry Discussed by CBR Pharma Insights in Its New Report Now Available at MarketPublishers.com
11 Aug 2017 • by Natalie Aster
LONDON – Though, the world’s pharmaceutical market is witnessing uptake, pharmaceuticals and biotechnology companies face a number of challenges owing to disruptive events in the healthcare field like escalating production and R&D costs, changes in patent laws and certain economic challenges. Market players are considering different strategies to stand up to these challenges, the deal-making is foremost amid the top measures to boost revenues for a short run.
Small companies, which primarily carry out early-stage research, development and production activities, use to enter into agreements with major industry leaders in order to out0license the rights to their products, using the strengths of the bigger companies in terms of commercialisation expertise, distribution, manufacturing and marketing capabilities and expand global presence. Besides, numerous companies have successfully implemented deal-making strategies in order to secure extended protection for their products from generic competitors.
Moreover, deal-making can help PharmaCos to enhance their R&D and regulatory approaches, spur portfolio expansion and diversification, encourage geographic expansion, support entry into niche markets and give a hand in commercialisation and sales.
The new topical research study “Pharmaceutical Deal Trends 2017 Factbook: Partnerships and Acquisitions Shift Focus Towards Early Stage Development, Emerging Markets, and Biologics” made by CBR Pharma Insights examines the importance of deal making activities in the world’s pharmaceutical and healthcare industries. The report features the main factors encouraging deal activity in these fields and discusses the major strategies that are being implemented during deal making. An insightful overview of the recent deal activity during 2010 – May 2017 is also at hand in this report.
Many other topical reports by CBR Pharma Insights are provided in the publisher’s catalogue at MarketPublishers.com.